Trial Profile
Evaluating quality of life in patients with non-small cell lung cancer treated with Nivolumab
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2016
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Nov 2016 New trial record